---
title: Ibogaine and its effects on PTSD and moral injury
videoId: X4QE6t-MkYE
---

From: [[hubermanlab]] <br/> 
In the exploration of [[psychedelics_for_treating_mental_disorders | psychedelics as potential treatments]] for mood disorders, ibogaine emerges as a substance with unique properties and substantial promise. Ibogaine is an alkaloid extracted from the root bark of the *Tabernanthe iboga* plant, traditionally used in religious rituals by the Bwiti people of Gabon, Africa. Its effects extend beyond the conventional understanding of psychedelics, offering a distinct therapeutic angle for addressing conditions like [[understanding_posttraumatic_stress_disorder_ptsd | PTSD]] and moral injury.

## Traditional Use and Cultural Context

Ibogaine has been used by the Bwiti people in Gabon for its sacramental and ceremonial purposes for generations. The traditional use of ibogaine involves consuming the root bark of the iboga plant in a ritualistic context, believed to facilitate spiritual journeys and introspection <a class="yt-timestamp" data-t="01:48:04">[01:48:04]</a>.

## Mechanism of Action

Unlike many other psychedelics, ibogaine does not induce visual or perceptual alterations of the external world. Instead, users report a phenomenon known as a "life review," where they re-experience past memories with a sense of empathy and detachment, allowing for re-evaluation and emotional processing <a class="yt-timestamp" data-t="01:49:30">[01:49:30]</a>. This introspective journey is often described as intense and non-recreational, offering a potential pathway to profound [[therapeutic_potential_of_psychedelics_for_trauma_and_brain_injury | psychological healing]].

## Clinical Application for PTSD

Dr. Nolan Williams highlights the exploration of ibogaine in treating [[psychological_and_neurobiological_aspects_of_ptsd | PTSD]], particularly among military veterans. These individuals often suffer from [[role_of_trauma_in_psychological_wellbeing | moral injuries]]—a psychological burden from actions perceived as deeply unethical or conflicting with one's moral beliefs, frequently occurring in combat scenarios <a class="yt-timestamp" data-t="01:55:00">[01:55:00]</a>.

### Therapeutic Framework

Ibogaine treatment sessions typically include a preparatory phase, the ibogaine experience—lasting approximately 24 to 36 hours—and post-session integration therapy. The goal of the treatment is to facilitate re-experiencing and reconsolidation of traumatic memories under the influence of ibogaine, allowing individuals to process and alleviate the psychological burdens associated with PTSD and moral injuries <a class="yt-timestamp" data-t="01:56:17">[01:56:17]</a>.

## Safety and Risks

Despite its therapeutic potential, ibogaine is not without risks. The primary concern lies in its cardiac effects, which necessitate careful screening and medical supervision to prevent adverse outcomes. However, with proper precautions, studies indicate ibogaine's potential to significantly aid those dealing with treatment-resistant forms of PTSD <a class="yt-timestamp" data-t="01:53:11">[01:53:11]</a>.

## Conclusion

Ibogaine represents a promising yet complex tool in the therapeutic arsenal against PTSD and moral injury. Its ability to induce profound introspection and memory reconsolidation holds significant promise, particularly for veterans seeking relief from psychological traumas. As research continues, understanding and refining the clinical applications of ibogaine will be critical to ensuring its safe and effective use.

> [!info] Note
> Ibogaine is currently not approved for medical use in the United States, and its use carries legal and health risks. All potential treatments should be considered under appropriate medical guidance and supervision.